FR2387975A1 - Nouveaux analogues de prostacycline et leur preparation - Google Patents

Nouveaux analogues de prostacycline et leur preparation

Info

Publication number
FR2387975A1
FR2387975A1 FR7732557A FR7732557A FR2387975A1 FR 2387975 A1 FR2387975 A1 FR 2387975A1 FR 7732557 A FR7732557 A FR 7732557A FR 7732557 A FR7732557 A FR 7732557A FR 2387975 A1 FR2387975 A1 FR 2387975A1
Authority
FR
France
Prior art keywords
preparation
new
prostacycline
analogues
analogs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7732557A
Other languages
English (en)
Other versions
FR2387975B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of FR2387975A1 publication Critical patent/FR2387975A1/fr
Application granted granted Critical
Publication of FR2387975B1 publication Critical patent/FR2387975B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0016—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing only hydroxy, etherified or esterified hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0041—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing nitrogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/94—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)

Abstract

L'invention est relative à de nouveaux analogues de dihydroprostacycline. Ces analogues sont des éthers 9-désoxy-5,9-cycliques de composés de prostaglandines du type F1 alpha , à un noyau hexagonal, la liaison entre la chaîne laterale et le noyau hétérocyclique étant une liaison saturée. Utilisations pharmaceutiques semblables à celles des dérivés connus de prostacycline.
FR7732557A 1977-04-19 1977-10-28 Nouveaux analogues de prostacycline et leur preparation Granted FR2387975A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US78814377A 1977-04-19 1977-04-19
US78814477A 1977-04-19 1977-04-19

Publications (2)

Publication Number Publication Date
FR2387975A1 true FR2387975A1 (fr) 1978-11-17
FR2387975B1 FR2387975B1 (fr) 1980-08-08

Family

ID=27120750

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7732557A Granted FR2387975A1 (fr) 1977-04-19 1977-10-28 Nouveaux analogues de prostacycline et leur preparation

Country Status (9)

Country Link
JP (1) JPS53132573A (fr)
AU (1) AU509357B2 (fr)
CA (1) CA1184906A (fr)
CH (1) CH636347A5 (fr)
DE (1) DE2746932A1 (fr)
FR (1) FR2387975A1 (fr)
GB (1) GB1554050A (fr)
NL (1) NL7800011A (fr)
SE (1) SE434266B (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2409997A1 (fr) * 1977-11-23 1979-06-22 Miles Lab
CZ303625B6 (cs) * 1999-10-15 2013-01-16 Sucampo Ag Stabilní farmaceutický prostredek obsahující bicyklickou slouceninu a acyglycerol, bicyklická sloucenina, zpusob stabilizace bicyklické slouceniny, farmaceutický prostredek obsahující bicyklickou slouceninu

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02294718A (ja) * 1989-05-09 1990-12-05 Fujitsu Ltd ディジタル信号入力回路
CN102498105B (zh) 2009-07-28 2014-04-02 小野药品工业株式会社 双环化合物及其医疗用途
WO2012102355A1 (fr) * 2011-01-27 2012-08-02 小野薬品工業株式会社 Composé bicyclique et son utilisation à des fins médicales
EP2669279B1 (fr) 2011-01-27 2017-01-11 ONO Pharmaceutical Co., Ltd. Composé bicyclique et utilisation associée à des fins médicales
ES2890989T3 (es) 2016-06-30 2022-01-25 Ono Pharmaceutical Co Método para producir un compuesto bicíclico

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2409997A1 (fr) * 1977-11-23 1979-06-22 Miles Lab
CZ303625B6 (cs) * 1999-10-15 2013-01-16 Sucampo Ag Stabilní farmaceutický prostredek obsahující bicyklickou slouceninu a acyglycerol, bicyklická sloucenina, zpusob stabilizace bicyklické slouceniny, farmaceutický prostredek obsahující bicyklickou slouceninu

Also Published As

Publication number Publication date
FR2387975B1 (fr) 1980-08-08
JPS53132573A (en) 1978-11-18
AU509357B2 (en) 1980-05-08
AU2820677A (en) 1979-03-01
SE434266B (sv) 1984-07-16
CA1184906A (fr) 1985-04-02
JPS6151597B2 (fr) 1986-11-10
NL7800011A (nl) 1978-10-23
SE7709477L (sv) 1978-10-20
DE2746932A1 (de) 1978-11-02
DE2746932C2 (fr) 1988-03-31
CH636347A5 (en) 1983-05-31
GB1554050A (en) 1979-10-17

Similar Documents

Publication Publication Date Title
FR2396749A1 (fr) Analogues de prostacycline
DE69311361D1 (de) Zusammensetzungen zur behandlung von glaukoma die prostaglandine und clonidinderivate enthalten
LU91541I2 (fr) latanoprost et ses dérivés pharmaceutiquement acceptables (XALATAN)
FR2372806A1 (fr) Pyrrolidones, leur procede de preparation et leur application therapeutique
FR2373513A1 (fr) Nouveaux derives du naphtalene, leur preparation et leur application comme medicaments
BE843590A (fr) Moyen pour reduire la fatigue due au port de chaussures
FR2387975A1 (fr) Nouveaux analogues de prostacycline et leur preparation
KR890006241A (ko) 설사약
US4201873A (en) 9-Deoxy-9,10-didehydro-PGD2 analogs
FR2453851A1 (fr) Analogues de la prostaglandine e1 et compositions pharmaceutiques les contenant
FR2358382A1 (fr) Nouveaux nonapeptides, leurs procedes de preparation et compositions pharmaceutiques les contenant
FR2361380A1 (fr) Nouveaux analogues de prostaglandines et leur preparation
FR2430418A1 (fr) Derives halogenomethyles d'a-aminoacides, leur preparation et leurs utilisations therapeutiques
FR2361877A1 (fr) Nouvelles lactones d'acides libres du type prostaglandine, leur preparation et medicament les contenant
FR2384745A1 (fr) Derives de la somatostatine et leur preparation
FR2361872A1 (fr) Nouveaux derives de prostaglandines et leur procede de preparation
FR2404005A1 (fr) Analogues de la prostaglandine i2 et compositions pharmaceutiques les contenant
FR2367742A1 (fr) Derives d'a-thio-alcanoiques, leur preparation et leur utilisation
FR2422653A1 (fr) Analogues de prostacycline
FR2392003A1 (fr) Analogues de prostaglandines comprenant un groupement methylene en position 9 et leur preparation
FR2401139A2 (fr) Nouveaux derives d5 de prostaglandines, leur procede de preparation et medicaments les contenant
FR2392005A1 (fr) Analogues de la prostaglandine e1 et les compositions pharmaceutiques qui les contiennent
SE7909480L (sv) 2,5-inter-o-fenylen-3,4-dinor-pfg och pg1 foreningar
CA1262912C (fr) Derives de substitution tetrahydrofuranyliques d'analogues de la prostaglandine
FR2362848A1 (fr) Nouvelles heterocyclo-omega-pentanorprostaglandines aryliques

Legal Events

Date Code Title Description
ST Notification of lapse